Skip to main content
. 2021 Dec 1;12(2):9128–9139. doi: 10.1080/21655979.2021.1993537

Figure 8.

Figure 8.

Correlation between overall survival of prostate cancer patients in YB-1, EGFR and CXCL14 expressing tissues. (a) The overall survival of prostate cancer patients with a high expression level of YB-1 was much lower than that of patients with a low level of YB-1(P = 0.0116); (b-d) There was no significant difference in the overall survival of prostate cancer patients with EGFR or CXCL14 expression levels or with Gleason score